Posted On: 12/10/2013 7:37:30 AM
Post# of 63863

From Pharma PRs

- Emergent BioSolutions' Otlertuzumab (TRU-016) Shows Positive Results in Combination with Rituximab in People with CLL
7:00 am - Business Wire

